MARKET RADAR
SENSEX     NIFTY      
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories
Divis Laboratories
BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 10, 15:47
754.50
-12.2 (-1.59%)
VOLUME 11,622
LIVE
NSE
Feb 10, 15:57
754.55
-12.8 (-1.67%)
VOLUME 149,420
News on Divis Laboratories
Select Year: 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Buy Divis Laboratories; target Rs 927: Emkay

3.48 pm | 01 Feb 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services is bullish on Divis Laboratories and has recommended buy rating on the stock with a target price of Rs 927 in its Janu...

Divis Labs Dec '11 sales at Rs 417.42 crore

6.28 pm | 31 Jan 2012 |  Source: Moneycontrol.com

Divis Laboratories has reported a sales turnover of Rs 417.42 crore and a net profit of Rs 122.55 crore for the quarter ended Dec '11...

Q3 earnings: Nirmal Bang reviews Glenmark, Divi's results 

1.18 pm | 31 Jan 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Praful Borah of Nirmal Bang Institutional Equities speak about Glenmark, Divi's results and gives his outlook going forw...

Pharma Q3: New launches, generic drug demand to aid growth

1.37 pm | 14 Jan 2012 |  Source: Moneycontrol.com

Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...

Pharmaceutical results preview for Q3FY12: Emkay

6.34 pm | 10 Jan 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services has come with its December quarterly earning estimates for pharmaceutical sector. According to the research firm the s...

KYI: Wrapping up 2011, what should you invest in 2012?

12.12 pm | 07 Jan 2012 |  Source: Moneycontrol.com

Know Your Investment, helps investors take a prudent call on their investments. This week, Hemang Mamtora, Vice President- Equity Advisory Desk, Emkay...

Bull's Eye: Buy MMTC, GMDC; short Adani Enter, IRB 

11.34 am | 02 Jan 2012 |  Source: Moneycontrol.com

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

Unicon recommends 8 stocks for long term investment

12.33 pm | 28 Nov 2011 |  Source: Moneycontrol.com

Unicon Investment has come out with its report on leveraged companies. The broking firm has identified have identified 8 companies with strong growth ...

Divis Labs Sep '11 sales at Rs 366.06 crore

11.19 am | 02 Nov 2011 |  Source: Moneycontrol.com

Divis Laboratories has reported a sales turnover of Rs 366.06 crore and a net profit of Rs 106.05 crore for the quarter ended Sep '11...

Buy Divis Labs; target of Rs 927: Motilal Oswal

3.22 pm | 16 Aug 2011 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Divis Labs and has recommended buy rating on the stock with a target of Rs 927 in its August 8, 2011 research report....

Divis Labs Jun '11 sales at Rs 364.81 crore

4.06 pm | 12 Aug 2011 |  Source: Moneycontrol.com

Divis Laboratories has reported a sales turnover of Rs 364.81 crore and a net profit of Rs 102.59 crore for the quarter ended Jun '11...

Sharekhan buys Glenmark Pharma, CESC; sells Lupin

3.26 pm | 12 Aug 2011 |  Source: Moneycontrol.com

Sharekhan has come out with its report on various stocks....

Buy Divi's Labs; Hold Madras Cem, Tata Global: Sharekhan

3.23 pm | 12 Aug 2011 |  Source: Moneycontrol.com

Sharekhan has come out with its report on various stocks....

1 2
Quick Links for Divis Laboratories
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.